Evidence map›Paper›PMID 26287742›Full record

ArticlePloS one2015

Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults.

Emmanuel Maganga, Luke R Smart, Samuel Kalluvya, Johannes B Kataraihya, Ahmed M Saleh, Lama Obeid, Jennifer A Downs, Daniel W Fitzgerald, Robert N Peck

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 53 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 7 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03106480 unknown statusnot on this mapstarted 2016, after this paper: background citation

Diabetes and Associated Complications in HIV Patients

TypeobservationalSponsorNational Institute for Medical Research, TanzaniaRan2016 to 2022Enrolled1,947ConditionsDiabetes Mellitus, HIV/AIDS
NCT03713502 unknown statusnot on this mapstarted 2019, after this paper: background citation

The Role of Environmental Enteropathy on HIV Associated Diabetes

TypeobservationalSponsorNational Institute for Medical Research, TanzaniaRan2019 to 2022Enrolled1,947ConditionsDiabetes, Environmental Enteropathy, HIV
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 7 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. The double burden of diabetes and global infection in low and middle-income countries.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2019
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Observational
  18. Journal of personalized medicine · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Emmanuel MagangaDepartment of Internal Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Luke R SmartDepartment of Internal Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania; Department of Internal Medicine, Bugando Medical Centre, Mwanza, Tanzania; Center for Global Health, Weill Cornell Medical College, New York, United States of America.
Samuel KalluvyaDepartment of Internal Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania; Department of Internal Medicine, Bugando Medical Centre, Mwanza, Tanzania.
Johannes B KataraihyaDepartment of Internal Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania; Department of Internal Medicine, Bugando Medical Centre, Mwanza, Tanzania.
Ahmed M SalehWeill Cornell Medical College in Qatar, Doha, Qatar.
Lama ObeidWeill Cornell Medical College in Qatar, Doha, Qatar.
Jennifer A DownsDepartment of Internal Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania; Department of Internal Medicine, Bugando Medical Centre, Mwanza, Tanzania; Center for Global Health, Weill Cornell Medical College, New York, United States of America.
Daniel W FitzgeraldCenter for Global Health, Weill Cornell Medical College, New York, United States of America.
Robert N PeckDepartment of Internal Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania; Department of Internal Medicine, Bugando Medical Centre, Mwanza, Tanzania; Center for Global Health, Weill Cornell Medical College, New York, United States of America.
Cornell University · USCatholic University of Health and Allied Sciences · TZWeill Cornell Medical College in Qatar · QABugando Medical Centre · TZCenter for Global Health · US

Funding

TUBERCULOSIS INTERNATIONAL TRAINING AND RESEARCH PROGRAMD43TW000018 · FIC · WEILL MEDICAL COLL OF CORNELL UNIV · PI JOHNSON, WARREN DOUGLAS · 1988 to 2012
$16.1M
Global Health Research Training in HIV and TuberculosisK24AI098627 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI FITZGERALD, DANIEL W · 2012 to 2022
$1.8M
FIC NIH HHS D43 TW000018FIC NIH HHS TW000018NIAID NIH HHS K24 AI098627
6 · The paper itself

Abstract

introductionMillions of HIV-infected Africans are living longer due to long-term antiretroviral therapy (ART), yet little is known about glucose metabolism disorders in this group. We aimed to compare the prevalence of glucose metabolism disorders among HIV-infected adults on long-term ART to ART-naïve adults and HIV-negative controls, hypothesizing that the odds of glucose metabolism disorders would be 2-fold greater even after adjusting for possible confounders.

methodsIn this cross-sectional study conducted between October 2012 and April 2013, consecutive adults (>18 years) attending an HIV clinic in Tanzania were enrolled in 3 groups: 153 HIV-negative controls, 151 HIV-infected, ART-naïve, and 150 HIV-infected on ART for ≥ 2 years. The primary outcome was the prevalence of glucose metabolism disorders as determined by oral glucose tolerance testing. We compared glucose metabolism disorder prevalence between each HIV group vs. the control group by Fisher's exact test and used multivariable logistic regression to determine factors associated with glucose metabolism disorders.

resultsHIV-infected adults on ART had a higher prevalence of glucose metabolism disorders (49/150 (32.7%) vs.11/153 (7.2%), p<0.001) and frank diabetes mellitus (27/150 (18.0%) vs. 8/153 (5.2%), p = 0.001) than HIV-negative adults, which remained highly significant even after adjusting for age, gender, adiposity and socioeconomic status (OR = 5.72 (2.78-11.77), p<0.001). Glucose metabolism disorders were significantly associated with higher CD4+ T-cell counts. Awareness of diabetes mellitus was <25%.

conclusionsHIV-infected adults on long-term ART had 5-fold greater odds of glucose metabolism disorders than HIV-negative controls but were rarely aware of their diagnosis. Intensive glucose metabolism disorder screening and education are needed in HIV clinics in sub-Saharan Africa. Further research should determine how glucose metabolism disorders might be related to immune reconstitution.

Indexed as

AdultAnti-HIV AgentsCD4 Lymphocyte CountCross-Sectional StudiesFemaleGlucose Metabolism DisordersHIV InfectionsHumansHypertensionMalePrevalenceRisk FactorsTanzaniaAnti-HIV Agents

Identifiers

PMID26287742
PMCPMC4545793
OpenAlexW1828330334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.